SOTERI SKIN

D2C Skincare for Eczema

Y CombinatorWinter 2022ActiveConsumerHome and PersonalE-commerceSkincare

What they do

Problem

People with chronic skin conditions like eczema struggle to maintain healthy skin barrier/pH balance and get long-lasting, non-prescription relief from irritation and sensitivity.

Solution

A direct-to-consumer skincare line using patented pH/LOCK™ technology to lock skin at a therapeutic pH for 12+ hours to reduce sensitivity and improve skin health without a prescription.

Who it's for

Individuals with eczema and other chronic skin conditions (e.g., psoriasis) seeking non-prescription skincare relief.

Founders

Rafal Pielak

Founder

My background is in product and business development. I received Ph.D. in Biomedical Chemistry and Molecular Pharmacology from Harvard Medical School and went on to complete my postdoctoral fellowship at UC Berkeley. Later I worked for biopharma identifying business opportunities in the rare disease space. Before launching Soteri Skin, I spent 7 years leading a product innovation team at L'Oreal where I helped to launch and grow L'Oreal Tech Incubator in San Francisco.